DavidA.PeuraMD

PubMed

• 12 citations
  Egyptian recommendations for management of Helicobacter pylori infection: 2018 report.
  Mohamed Alboraie, Walied Elhossary, Osama Aboelfotoh Aly, Bahaa Abbas, Lobna Abdelsalam, Doaa Ghaith, Zakarya M. Shady, Yasmine Gaber, Eman Adel, David A. Peura, David...> ;Arab Journal of Gastroenterology. 2019 Sep 26
• 1 citations
  Analysis of the symptom response to esomeprazole 20 mg over days 1-4 of a 14-day course of treatment for frequent heartburn: results of two randomised controlled trials
  David A. Peura, Anne Le Moigne, Heather Wassel, Charles Pollack> ;BMJ Open Gastroenterology. 2019 Jun 1
• 3 citations
  Sustained efficacy following resolution of frequent heartburn with an over-the-counter regimen of esomeprazole 20 mg or placebo for 14 days: two randomized trials.
  David A. Peura, Anne Le Moigne, Heather Wassel, Charles Pollack> ;BMC Gastroenterology. 2018 May 22
• 285 citations
  25 Years of Proton Pump Inhibitors: A Comprehensive Review.
  Daniel S. Strand, Daejin Kim, David A. Peura> ;Gut and Liver. 2017 Jan 15
• 6 citations
  Managing gastroesophageal reflux disease - comparative efficacy and outcomes of dexlansoprazole MR.
  Jeanetta Frye, David A. Peura> ;Therapeutics and Clinical Risk Management. 2015 Oct 30
• 4 citations
  A 14-day regimen of esomeprazole 20 mg/day for frequent heartburn: durability of effects, symptomatic rebound, and treatment satisfaction.
  David A. Peura, Anne Le Moigne, Charles Pollack, Peter Nagy, Tore Lind> ;Postgraduate Medicine. 2016 Jul 4
• 8 citations
  Esomeprazole Treatment of Frequent Heartburn: Two Randomized, Double-Blind, Placebo-Controlled Trials
  David A. Peura, Barry Traxler, Christopher Kocun, Tore Lind> ;Postgraduate Medicine. 2014 Jul 1
• 3 citations
  Pharmacodynamic evaluation of intragastric pH and implications for famotidine dosing in the prophylaxis of non-steroidal anti-inflammatory drug induced gastropathy—a p...
  Jeffery D. Kent, Robert J. Holt, Donald Jung, George F. Tidmarsh, Amy Y. Grahn, Julie Ball, David A. Peura> ;Journal of Drug Assessment. 2014 Feb 17
• 5 citations
  Aspirin and proton pump inhibitor combination therapy for prevention of cardiovascular disease and Barrett's esophagus.
  David A. Peura, C. Mel Wilcox> ;Postgraduate Medicine. 2014 Jan 1
• 9 citations
  Distinguishing the impact of dexlansoprazole on heartburn vs. regurgitation in patients with gastro-oesophageal reflux disease.
  David A. Peura, Betsy Pilmer, Barbara Hunt, Reema Mody, Maria Claudia Perez> ;Alimentary Pharmacology & Therapeutics. 2013 Nov 1
• 13 citations
  The use of H2 antagonists in treating and preventing NSAID-induced mucosal damage
  Anne Tuskey, David A. Peura> ;Arthritis Research & Therapy. 2013 Jul 24
• 13 citations
  The effects of increasing body mass index on heartburn severity, frequency and response to treatment with dexlansoprazole or lansoprazole.
  David A. Peura, Betsy Pilmer, Barbara Hunt, Reema Mody, Maria Claudia Perez> ;Alimentary Pharmacology & Therapeutics. 2013 Apr 1
• 7 citations
  Budget impact modeling for a single-tablet formulation of ibuprofen and famotidine for prevention of upper gastrointestinal ulcers in patients with osteoarthritis and/...
  Renee Kuan, Robert J. Holt, Kenneth E. Johnson, Jeffrey D Kent, David A. Peura, Daniel C. Malone> ;Clinical Therapeutics. 2013 Mar 1
• 26 citations
  Risk factors associated with a decrease ≥2 g/dL in haemoglobin and/or ≥10% haematocrit in osteoarthritis patients taking celecoxib or a nonselective NSAID plus a PPI i...
  Angel Lanas, Jay L. Goldstein, Francis K.L. Chan, Charles M. Wilcox, David A. Peura, C. Li, Sands George Harry, James M. Scheiman> ;Alimentary Pharmacology & Therapeutics. 2012 Sep 1
• 16 citations
  HZT-501 (DUEXIS®; ibuprofen 800 mg/famotidine 26.6 mg) gastrointestinal protection in the treatment of the signs and symptoms of rheumatoid arthritis and osteoarthritis
  Michael Schiff, David A. Peura> ;Expert Review of Gastroenterology & Hepatology. 2012 Feb 1
• 31 citations
  Haemoglobin decreases in NSAID users over time: an analysis of two large outcome trials.
  Jay L. Goldstein, Francis K.L. Chan, Angel Lanas, Charles M. Wilcox, David A. Peura, Sands George Harry, Manuela F. Berger, H. Nguyen, James M. Scheiman> ;Alimentary Pharmacology & Therapeutics. 2011 Oct 1
• 49 citations
  The prevalence and incidence of Helicobacter pylori-associated peptic ulcer disease and upper gastrointestinal bleeding throughout the world.
  Andrew Y. Wang, David A. Peura> ;Gastrointestinal Endoscopy Clinics of North America. 2011 Oct 1
• 5 citations
  Barrett's esophagus: prevalence and incidence of adenocarcinomas.
  Helen M. Shields, Gerardo Nardone, Jingjing Zhao, Wen Wang, Zheng Xing, Dianchun Fang, Brian C. Jacobson, Yvonne Romero, Katerina Dvorak, Aaron Goldman, Carlos A. Pell...> ;Annals of the New York Academy of Sciences. 2011 Sep 1
• 14 citations
  Dexlansoprazole MR for the management of gastroesophageal reflux disease
  Brian W Behm, David A. Peura> ;Expert Review of Gastroenterology & Hepatology. 2011 Aug 1
• 8 citations
  The Value of Branded Proton Pump Inhibitors: Formulary Considerations
  David A. Peura, Rosemary R. Berardi, Javier Gonzalez, Louis Brunetti> ;P & T. 2011 Jul 1
• 54 citations
  Bleeding after percutaneous endoscopic gastrostomy is linked to serotonin reuptake inhibitors, not aspirin or clopidogrel.
  James A. Richter, James T. Patrie, Robert P. Richter, Zachary Henry, George H. Pop, Kara A. Regan, David A. Peura, Robert G. Sawyer, Patrick G. Northup, Andrew Y. Wang> ;Gastrointestinal Endoscopy. 2011 Jul 1
• [Personal vision of the future based on 10-th Congress OESO].
  David A Peura> ;Eksperimental'naia i Klinicheskaia Gastroenterologiia = Experimental & Clinical Gastroenterology. 2011 Jan 1
• 6 citations
  Review of proton pump inhibitors for the initial treatment of heartburn: Is there a dose ceiling effect?
  Pamela R. Kushner, David A. Peura> ;Advances in Therapy. 2011 Apr 6
• 6 citations
  The 12-month safety profile of dexlansoprazole, a proton pump inhibitor with a dual delayed release formulation, in patients with gastro-oesophageal reflux disease.
  A. H. Dabholkar, Cong Han, M. M. Paris, Maria Claudia Perez, Stuart Atkinson, David A. Peura> ;Alimentary Pharmacology & Therapeutics. 2011 Feb 1
• 45 citations
  Meshed capillary vessels found on narrow-band imaging without optical magnification effectively identifies colorectal neoplasia: a North American validation of the Jap...
  Zachary Henry, Paul Yeaton, Vanessa M. Shami, Michel Kahaleh, James T. Patrie, Dawn G. Cox, David A. Peura, Fabian Emura, Andrew Y. Wang> ;Gastrointestinal Endoscopy. 2010 Jul 1
• Join now to see all